Vorapaxar 2.5 mg

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

AtherosclerosisCerebral InfarctionCerebrovascular AccidentIschemiaMyocardial Infarction

Phase 2

Trial to Assess the Safety of Vorapaxar in Japanese Subjects With Cerebral Infarction (P05005; MK-5348-017)

CompletedNCT00684515

Merck Sharp & Dohme LLCCerebral Infarction

Start: 2006-09-21End: 2007-11-08Updated: 2018-09-21

Phase 3

Trial to Assess the Ocular Safety of Vorapaxar (SCH 530348) in Participants With Atherosclerosis (Study P05183)

CompletedNCT00617123

Merck Sharp & Dohme LLCAtherosclerosis, Cerebrovascular Accident, Ischemia +1

Start: 2008-07-01End: 2010-10-01Updated: 2018-09-21